6.6.2017 11:02 | Business Wire
ibis mobile Releases Deep-Learning-Based Auto Paint for Drawing App ibis Paint
ibis mobile inc. (head office: Chuo-ku, Tokyo; President/CEO: Eiji Kamiya) released an additional function for social drawing app ibis Paint. Using deep learning, the function enables automatic painting based on line drawings.
This Smart News Release features multimedia. View the full release here: http://www.businesswire.com/news/home/20170606005695/en/
Watch how auto paint works
ibis Paint, a popular social drawing app with 8 million downloads, now features deep-learning-based automatic painting for line drawings. On the ibis Paint social site, many artworks are posted every day, with more than 600 thousand user-created works on the server. We selected about 300 thousand artworks suitable for deep learning from over 600 thousand posts, performed some image processing of the artworks in advance and used them to develop the new function through several months of trial and error-based research and development by using AWS’s machine learning cloud server (P2 instance) in Oregon in the U.S.
For users, this is a new art tool that is expected to enable new ways of expression. After the release, users’ posts on the ibis Paint social site are expected to help us understand their drawing trend, which will lead to higher accuracy and better recognition of diverse line drawings of people, objects, and landscapes.
The current function can recognize people’s face, hair, eye, cheek, and mouth, and lines between people and objects. Not all of these are painted with colors that users expect. An assist function addresses this situation, allowing users to specify colors. With this, users can paint in a short period of time.
This is our first commercial function that leverages deep learning. We plan to continue research to enable new ways of expression and labor saving using deep learning for drawing. Ultimately, we aim to develop artificial intelligence that assists professional cartoonists, illustrators, and animation creators to save labor and improve efficiency.
Fig. 1 shows how to experience AI auto paint. First, search ibis Paint
on App Store or Google Play Store, and download a free version. Then
have a line drawing ready.
1. Tap My Gallery on title screen
2. Tap + on My Gallery
3. Tap Import Picture to load a line drawing and adjust the loading position
4. Tap tool selection window
5. Tap filters
6. Tap Auto Paint
Then auto paint is executed. If you want to use the color specification assist function, open the color selection window, choose a brush color, and apply color by tapping inside the line drawing. The result is nicer when you put color with a series of tapping motions rather than specifying a color with long lines.
Fig. 2 shows the results of some line drawings to which auto paint and color specification assist are applied.
|Developer||ibis mobile inc.|
|Name of app||
Free version: ibis Paint X
Requires iOS 8.0 or later
Free version: Free
Number of posts: 663,585
ibis Paint X iOS edition (free):
Information om Business Wire
101 California Street, 20th Floor
CA 94111 San Francisco
Følg pressemeddelelser fra Business Wire
Ved at skrive dig op her, vil du modtage pressemeddelelser på mail når de udsendes. Indtast din mail og følg instruktionerne. Det er ligeså let at melde sig fra igen.
Flere pressemeddelelser fra Business Wire
NY-MOODY’S24.7.2017 16:02 | pressemeddelelse
Moody’s Analytics Voted Best Credit Risk Solution Provider in Waters Rankings for Second Year in a Row
SYNECTICS24.7.2017 16:01 | pressemeddelelse
Synectics Wins European Contract for Train-to-Ground ‘Passenger Help’ Solution
NY-CALVIN-KLEIN24.7.2017 15:02 | pressemeddelelse
Calvin Klein, Inc. Announces Fall 2017 CALVIN KLEIN 205W39NYC Global Advertising Campaign
SAMSUNG-BIOEPIS24.7.2017 14:06 | pressemeddelelse
Samsung Bioepis Announces RENFLEXIS™ (infliximab-abda) Now Available in the United States
MAVENIR24.7.2017 12:02 | pressemeddelelse
Mavenir Announces R & D Center of Excellence Focused on 5G Network and Services
CA-GILEAD-SCIENCES,-INC.24.7.2017 11:08 | pressemeddelelse
Gilead Announces Phase 3 Results for Investigational Fixed-Dose Combination of Bictegravir, Emtricitabine and Tenofovir Alafenamide for Treatment of HIV
I vores nyhedsrum kan du læse alle vores pressemeddelelser, tilgå materiale i form af billeder og dokumenter, og finde vores kontaktoplysninger.Besøg vores nyhedsrum